In our previous study, we have shown that high PLK1 protein expression was significantly correlated with higher clinical stage, advanced tumor classification and lymph node metastasis of NSCLC patients and might be a poor prognostic molecular marker[8]. This evidence concerns the gene PLK1 and non-small cell lung carcinoma.